Differences in clinical features and prognosis between hypertriglyceridemia and other causes of acute pancreatitis: a dual perspective based on metabolic disorders and inflammatory response - Scorecard - MDSpire
Advertisement
Differences in clinical features and prognosis between hypertriglyceridemia and other causes of acute pancreatitis: a dual perspective based on metabolic disorders and inflammatory response
Clinical Scorecard: Comparative Analysis of Clinical Characteristics and Outcomes in Hypertriglyceridemia-Induced Acute Pancreatitis Versus Other Etiologies: Insights from Metabolic and Inflammatory Perspectives
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Patients with acute pancreatitis, particularly those with hypertriglyceridemia, aged 18 and above.
Care Setting
Key Highlights
HTG-AP patients are significantly younger than non-HTG-AP patients (P < 0.001).
Higher prevalence of diabetes and metabolic disorders in HTG-AP group (P < 0.001).
Increased rates of moderately severe and severe acute pancreatitis in HTG-AP (P < 0.05).
Higher ICU admission rates for HTG-AP patients (P < 0.05).
Increased long-term risk of post-acute pancreatitis diabetes mellitus (PPDM-A) in HTG-AP (P < 0.05).
Guideline-Based Recommendations
Diagnosis
Diagnosis of HTG-AP requires serum triglycerides > 1000 mg/dL or 500-1000 mg/dL with chylous serum, as per the American Diabetes Association guidelines.
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
HTG-AP patients exhibit more severe metabolic disturbances and systemic inflammation; consider discussing specific treatment options.
Clinical Best Practices
Early identification and management of hypertriglyceridemia in acute pancreatitis, supported by recent studies.
Regular follow-up for glucose metabolism abnormalities post-acute pancreatitis, as recommended by the American Diabetes Association.
